Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics
HBIO Price/Volume Stats
| Current price | $2.83 | 52-week high | $5.56 |
| Prev. close | $2.86 | 52-week low | $2.61 |
| Day low | $2.73 | Volume | 62,200 |
| Day high | $2.87 | Avg. volume | 112,212 |
| 50-day MA | $3.00 | Dividend yield | N/A |
| 200-day MA | $3.85 | Market Cap | 122.91M |
HBIO Stock Price Chart Interactive Chart >
Harvard Bioscience, Inc. (HBIO) Company Bio
Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.
Latest HBIO News From Around the Web
Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executi |
With 60% ownership, Harvard Bioscience, Inc. (NASDAQ:HBIO) boasts of strong institutional backingKey Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their... |
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The Company’s presentation will begin at 9:40 AM ET / 8:40 AM CT on November 16th. A replay of the presentation will be |
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call TranscriptHarvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript November 7, 2023 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.04. Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. […] |
Q3 2023 Harvard Bioscience Inc Earnings CallQ3 2023 Harvard Bioscience Inc Earnings Call |
HBIO Price Returns
| 1-mo | -2.08% |
| 3-mo | -2.25% |
| 6-mo | -30.12% |
| 1-year | -32.30% |
| 3-year | -63.20% |
| 5-year | -10.44% |
| YTD | -47.10% |
| 2023 | 93.14% |
| 2022 | -60.71% |
| 2021 | 64.34% |
| 2020 | 40.66% |
| 2019 | -4.09% |
Continue Researching HBIO
Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...